Thomas Cartwright
MD
Associate Professor of Medicine
University of Central Florida School of Medicine

Thomas Cartwright, MD, has served as the Associate Chair of the Research Gastrointestinal Program for US Oncology Research and Chairman of the Pathways Task Force for GI Cancers. He has over 30 years of experience in internal medicine and medical oncology with a special expertise in Epidemiology, Gastrointestinal Cancer and General Oncology. He has been on the staff of several area hospitals including Munroe Regional Medical Center, Ocala Regional Medical Center and West Marion Community Hospital. He has given a numerous lectures on cancer care and has published more than 100 articles in such journals as Cancer Research, New England Journal of Medicine and Journal of Clinical Oncology. Dr. Cartwright received his medical degree from Northwestern University Medical School in Chicago, completed a residency in internal medicine at Southern Illinois School of Medicine in Springfield, and his fellowship at Emory University School of Medicine in Atlanta. Dr. Cartwright is a Diplomat of the American Board of Internal Medicine with subspecialty certification in medical oncology. Dr Cartwright is currently an Associate Professor of Medicine at the University of Central Florida School of Medicine.

Sessions

Register
General Session

Session 4: Optimizing Outcomes in Advanced/Metastatic Gastric and Gastroesophageal Junction Cancer: A Focus on Novel and Emerging HER2-Negative Targeted Treatment Strategies

Friday, May 17, 2024
11:55 AM - 12:25 PM
General Session

Session 5: Targeting HER2 Overexpression in Gastroesophageal and Colorectal Cancers: Novel and Emerging Options

Friday, May 17, 2024
1:45 PM - 2:15 PM
General Session

Optimizing Outcomes in Advanced/Metastatic Gastric and Gastroesophageal Junction Cancer: A Focus on Novel and Emerging HER2-Negative Targeted Treatment Strategies

Saturday, October 19, 2024
10:35 AM - 11:15 AM
General Session

Targeting HER2 Overexpression in Gastroesophageal and Colorectal Cancers: Novel and Emerging Options

Saturday, October 19, 2024
1:35 PM - 2:15 PM